Search Results - "CAI, MENGYIN"
-
1
The many faces of diabetes: a disease with increasing heterogeneity
Published in The Lancet (British edition) (22-03-2014)“…Summary Diabetes is a much more heterogeneous disease than the present subdivision into types 1 and 2 assumes; type 1 and type 2 diabetes probably represent…”
Get full text
Journal Article -
2
Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney
Published in Kidney international (01-02-2016)“…Diabetic kidney disease is the leading cause of end-stage renal disease. Genetic factors have been suggested to contribute to its susceptibility. However,…”
Get more information
Journal Article -
3
Epigenetic regulation of glucose-stimulated osteopontin (OPN) expression in diabetic kidney
Published in Biochemical and biophysical research communications (01-01-2016)“…Diabetes nephropathy (DN) is the leading cause of end stage renal disease and it affects up to 40% of diabetic patients. In addition to hyperglycemia, genetic…”
Get full text
Journal Article -
4
Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD
Published in Cell reports (Cambridge) (25-04-2023)“…Protein post-translational modifications (PTMs) participate in important bioactive regulatory processes and therefore can help elucidate the pathogenesis of…”
Get full text
Journal Article -
5
Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis
Published in Nutrition & diabetes (12-04-2024)“…Background The effectiveness of ketogenic diet (KD) in ameliorating fatty liver has been established, although its mechanism is under investigation. Fibroblast…”
Get full text
Journal Article -
6
Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice
Published in Oncology reports (01-03-2016)“…Studies have showed that diabetes is one of the high risk factors of endometrial cancer; however, no reports describe the anti- or pro-cancer effect of a new…”
Get full text
Journal Article -
7
The SRE Motif in the Human PNPLA3 Promoter (−97 to −88 bp) Mediates Transactivational Effects of SREBP-1c
Published in Journal of cellular physiology (01-09-2015)“…Patatin‐like phospholipase domain containing 3 (PNPLA3) is a non‐secreted protein primarily expressed in liver and adipose tissue. Recently, numerous genetic…”
Get full text
Journal Article -
8
Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription
Published in Diabetologia (01-03-2014)“…Aims/hypothesis Sterol regulatory element binding protein-1c (SREBP-1c) is a master regulator of fatty acid synthase and controls lipogenesis. IRS-1 is the key…”
Get full text
Journal Article -
9
Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis
Published in Endocrine Connections (01-10-2020)“…Background: Obesity is associated with the development and progression of chronic kidney disease. Emerging evidence suggests that glucagon-like peptide-1…”
Get full text
Journal Article -
10
Insight into the biochemical characteristics of a novel glucokinase gene mutation
Published in Human genetics (01-03-2011)“…Glucokinase (GCK) acts as a glucose sensor and regulates β-cell insulin secretion. The heterozygous mutations in the gene encoding GCK cause a reduction of the…”
Get full text
Journal Article -
11
Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate
Published in Laboratory investigation (01-09-2011)“…The molecular impact of diabetes mellitus on prostate gland has not been elucidated. In this study, we performed a whole-genome cDNA microarray analysis using…”
Get full text
Journal Article -
12
6q24 transient neonatal diabetes mellitus: the first case report from China
Published in Chinese medical journal (2014)“…To the editor: Neonatal diabetes mellitus (NDM) is one kind of monogenic diabetes which usually presents within 6 months after birth and needs insulin…”
Get full text
Journal Article -
13
Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element–binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat–diet and streptozotocin-induced diabetic rats
Published in Metabolism, clinical and experimental (01-06-2009)“…Abstract We previously reported that early insulin treatment reduced intramuscular triglyceride content in type 2 diabetes mellitus Sprague-Dawley rats; the…”
Get full text
Journal Article -
14
SIRT1/HSF1/HSP pathway is essential for exenatide‐alleviated, lipid‐induced hepatic endoplasmic reticulum stress
Published in Hepatology (Baltimore, Md.) (01-09-2017)“…Recent studies have indicated that lipid‐induced endoplasmic reticulum (ER) stress is a major contributor to the progression of hepatic steatosis. Exenatide…”
Get full text
Journal Article -
15
SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis
Published in Metabolism, clinical and experimental (01-09-2023)“…Activation of hepatic stellate cells (HSCs), the central event of fibrosis, indicates the severe stage of non-alcoholic fatty liver disease (NAFLD). MicroRNAs…”
Get full text
Journal Article -
16
1572-P: Lipotoxicity-Induced TET1 Mediates CD36 DNA Demethylation in Liver Macrophages to Aggravate NAFLD Progression
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Aims: DNA methylation is dysregulated in nonalcoholic fatty liver disease (NAFLD), yet the dominant genes and regulatory mechanisms remain obscure. Here,…”
Get full text
Journal Article -
17
394-P: Empagliflozin Ameliorate Renal Fibrosis in DKD
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Introduction & Objective: Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve renal outcomes in diabetic kidney disease (DKD), but the mechanisms…”
Get full text
Journal Article -
18
1784-LB: LRP5 Promotes Fatty Acid Oxidation through Enhancement of PPAR/PGC-1 Signaling in DKD with Dyslipidemia
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Dyslipidemia is an independent risk factor for diabetic kidney disease (DKD), but some lipid-lowering drugs are reported to exacerbate this disease, as they…”
Get full text
Journal Article -
19
520-P: Exenatide Ameliorates Diabetic Kidney Disease by Inhibiting Apoptosis via SIRT1/TXNIP Signal Pathway
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Recent studies have indicated apoptosis to be a major contributor to the progression of Diabetic Kidney Disease. GLP-1 agonist such as Exenatide, which…”
Get full text
Journal Article -
20
1138-P: Empagliflozin Ameliorates Kidney Injury in Diabetic Nephropathy via SIRT1 and TXNIP
Published in Diabetes (New York, N.Y.) (01-06-2020)“…SGLT2 inhibitor empagliflozin can slower the decline of eGFR and reduce the occurrence rate of end-stage kidney disease according to EMPA-REG OUTCOME Clinical…”
Get full text
Journal Article